30/10/2006
'Sticking plaster' hope for skin cancer
A new light-emitting 'sticking plaster' to be used in the treatment of skin cancer, has been developed by Scottish scientists.
Researchers at the University of St Andrews and Ninewells Hospital in Dundee, developed the new device, which builds on established photodynamic therapy treatment methods.
Scientists said that the device not only reduces pain, but can also potentially be used by patients in their own home.
The device is a portable lightweight source which is powered by a pocket-sized battery, so that patients should be able to go about their daily business while receiving treatment. The light is generated by an organic light-emitting diode.
The device was developed by a team headed by St Andrews' physicist Professor Ifor Samuel and dermatology consultant Professor James Ferguson, head of the photobiology unit at Ninewells Hospital.
Professor Samuel said: "By adapting the latest technology to an existing treatment method, we have developed a compact light source for treating common skin cancers. It can be worn by the patient in a similar way to a sticking plaster, while the battery is carried like an iPod."
Professor Ferguson said: "This new device will have a major impact on the treatment of skin cancers. The light-emitting patch is a low-cost, portable and convenient method of treatment. Our initial pilot trials have already shown its effectiveness and we find patients requesting this treatment over conventional methods."
Scientists said that the new approach is much more convenient and comfortable than conventional methods as lower light levels are used, which reduces pain, and the patient can move around during treatment. The introduction of this product will mean that more patients can be treated, and opens up the possibility of treatment at GPs surgeries or at home.
Skin cancer is a major problem in the UK and is growing. It is estimated that around 10% of Scotland's population of half-a-million people will suffer from the disease at some point in their lifetimes.
Researchers also believe that the treatment could be used in the cosmetic industry, for anti-aging treatments or for conditions such as acne.
(KMcA)
Researchers at the University of St Andrews and Ninewells Hospital in Dundee, developed the new device, which builds on established photodynamic therapy treatment methods.
Scientists said that the device not only reduces pain, but can also potentially be used by patients in their own home.
The device is a portable lightweight source which is powered by a pocket-sized battery, so that patients should be able to go about their daily business while receiving treatment. The light is generated by an organic light-emitting diode.
The device was developed by a team headed by St Andrews' physicist Professor Ifor Samuel and dermatology consultant Professor James Ferguson, head of the photobiology unit at Ninewells Hospital.
Professor Samuel said: "By adapting the latest technology to an existing treatment method, we have developed a compact light source for treating common skin cancers. It can be worn by the patient in a similar way to a sticking plaster, while the battery is carried like an iPod."
Professor Ferguson said: "This new device will have a major impact on the treatment of skin cancers. The light-emitting patch is a low-cost, portable and convenient method of treatment. Our initial pilot trials have already shown its effectiveness and we find patients requesting this treatment over conventional methods."
Scientists said that the new approach is much more convenient and comfortable than conventional methods as lower light levels are used, which reduces pain, and the patient can move around during treatment. The introduction of this product will mean that more patients can be treated, and opens up the possibility of treatment at GPs surgeries or at home.
Skin cancer is a major problem in the UK and is growing. It is estimated that around 10% of Scotland's population of half-a-million people will suffer from the disease at some point in their lifetimes.
Researchers also believe that the treatment could be used in the cosmetic industry, for anti-aging treatments or for conditions such as acne.
(KMcA)
Related UK National News Stories
Click here for the latest headlines.
22 September 2008
Scottish Government Pledges Cap On Surgery Waiting Times
Scottish patients may soon have a legal guarantee that they will wait no longer than 12 weeks for surgery. The Scottish Government's Patient Rights Bill proposes a strict limit on how long they have to wait from their surgical referral to receiving their operation.
Scottish Government Pledges Cap On Surgery Waiting Times
Scottish patients may soon have a legal guarantee that they will wait no longer than 12 weeks for surgery. The Scottish Government's Patient Rights Bill proposes a strict limit on how long they have to wait from their surgical referral to receiving their operation.
17 April 2009
Older Stroke Patients Get Poorer Treatment, Says BMJ
Older people are less likely to receive drug treatment after a stroke compared to younger people, despite the fact that treatment is equally effective. A study published on bmj.
Older Stroke Patients Get Poorer Treatment, Says BMJ
Older people are less likely to receive drug treatment after a stroke compared to younger people, despite the fact that treatment is equally effective. A study published on bmj.
07 January 2005
Reid hails mobile treatment centres as success
According to a report published today more than 120,000 patients have been treated since the start of the government's pioneering Treatment Centre programme, in some cases up to eight times faster than traditional NHS providers.
Reid hails mobile treatment centres as success
According to a report published today more than 120,000 patients have been treated since the start of the government's pioneering Treatment Centre programme, in some cases up to eight times faster than traditional NHS providers.
06 July 2005
Patients prefer better care to faster treatment, report claims
Patients would prefer to wait for better hospital treatment, rather than go to a hospital with shorter waiting lists. A study, conducted by RAND Europe, the King’s Fund and City University, found that patients were more likely to choose to be treated at a hospital with a good reputation rather than one that has shorter waiting times.
Patients prefer better care to faster treatment, report claims
Patients would prefer to wait for better hospital treatment, rather than go to a hospital with shorter waiting lists. A study, conducted by RAND Europe, the King’s Fund and City University, found that patients were more likely to choose to be treated at a hospital with a good reputation rather than one that has shorter waiting times.
04 August 2004
NHS patients not consulted enough during treatment, says survey
Many NHS patients are not involved enough in decisions about their care and so cannot give meaningful consent to treatment, according to the Healthcare Commission. Over 300,000 patients were asked about their experiences in 568 English NHS trusts for five commission the surveys published today.
NHS patients not consulted enough during treatment, says survey
Many NHS patients are not involved enough in decisions about their care and so cannot give meaningful consent to treatment, according to the Healthcare Commission. Over 300,000 patients were asked about their experiences in 568 English NHS trusts for five commission the surveys published today.